1-7 of 7
Lise Tarnow, MD, DMSC
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tubular and Glomerular Injury in Diabetes and the Impact of ACE Inhibition

Stine E. Nielsen, MD, Takeshi Sugaya, MD, PHD, Lise Tarnow, MD, DMSC, Maria Lajer, CANDSCI, Katrine J. Schjoedt, MD, Anne Sofie Astrup, MD, Tsuneharu Baba, MD, PHD, Hans-Henrik Parving, MD, DMSC, Peter Rossing, MD, DMSC
Journal: Diabetes Care
Diabetes Care 2009;32(9):1684–1688
DOI: https://doi.org/10.2337/dc09-0429
Published: 05 June 2009
View article
PDF
Journal Articles

YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria

Camilla Noelle Rathcke, MD, Frederik Persson, MD, Lise Tarnow, MD, DMSC, Peter Rossing, MD, DMSC, Henrik Vestergaard, MD, DMSC
Journal: Diabetes Care
Diabetes Care 2009;32(2):323–328
DOI: https://doi.org/10.2337/dc08-1144
Published: 01 February 2009
View article
PDF
Journal Articles

Plasma Connective Tissue Growth Factor Is an Independent Predictor of End-Stage Renal Disease and Mortality in Type 1 Diabetic Nephropathy

Tri Q. Nguyen, MD, Lise Tarnow, MD, DMSC, Anders Jorsal, Noelynn Oliver, PHD, Peggy Roestenberg, PHD, Yasuhiko Ito, MD, Hans-Henrik Parving, MD, DMSC, Peter Rossing, MD, DMSC, Frans A. van Nieuwenhoven, PHD, Roel Goldschmeding, MD, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(6):1177–1182
DOI: https://doi.org/10.2337/dc07-2469
Published: 01 June 2008
View article
PDF
Journal Articles

The Xylosyltransferase I Gene Polymorphism c.343G>T (p.A125S) Is a Risk Factor for Diabetic Nephropathy in Type 1 Diabetes

Sylvia Schön, PHD, Christian Prante, MS, Claudia Bahr, MS, Lise Tarnow, MD, DMSC, Joachim Kuhn, PHD, Knut Kleesiek, MD, Christian Götting, PHD
Journal: Diabetes Care
Diabetes Care 2006;29(10):2295–2299
DOI: https://doi.org/10.2337/dc06-0344
Published: 01 October 2006
View article
PDF
Journal Articles

Urinary Connective Tissue Growth Factor Excretion Correlates With Clinical Markers of Renal Disease in a Large Population of Type 1 Diabetic Patients With Diabetic Nephropathy

Tri Q. Nguyen, MD, Lise Tarnow, MD, DMSC, Steen Andersen, MD, DMSC, Peter Hovind, MD, DMSC, Hans-Henrik Parving, MD, DMSC, Roel Goldschmeding, MD, PHD, Frans A. van Nieuwenhoven, PHD
Journal: Diabetes Care
Diabetes Care 2006;29(1):83–88
DOI: https://doi.org/10.2337/diacare.29.01.06.dc05-1670
Published: 01 January 2006
View article
PDF
Journal Articles

Elevated Plasma Asymmetric Dimethylarginine as a Marker of Cardiovascular Morbidity in Early Diabetic Nephropathy in Type 1 Diabetes

Lise Tarnow, MD, DMSC, Peter Hovind, MD, Tom Teerlink, PHD, Coen D.A. Stehouwer, MD, PHD, Hans-Henrik Parving, MD, DMSC
Journal: Diabetes Care
Diabetes Care 2004;27(3):765–769
DOI: https://doi.org/10.2337/diacare.27.3.765
Published: 01 March 2004
View article
PDF
Journal Articles

Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype?

Steen Andersen, MD, Lise Tarnow, MD, DMSC, Francois Cambien, MD, Peter Rossing, MD, DMSC, Tina R. Juhl, Jaap Deinum, MD, Hans-Henrik Parving, MD, DMSC
Journal: Diabetes Care
Diabetes Care 2003;26(5):1501–1506
DOI: https://doi.org/10.2337/diacare.26.5.1501
Published: 01 May 2003
View article
PDF